Physicians' Academy for Cardiovascular Education

Atrial fibrillation

Updates in the 2020 AF guidelines

3' education - Sep. 2, 2020 - Prof. Isabelle van Gelder, MD

Early rhythm control in AF patients improves outcomes

3' education - Aug. 29, 2020 - Prof. Paulus Kirchhof, MD

Oral anticoagulant monotherapy reduces bleeding in AF patients after TAVI

3' education - Mar. 30, 2020 - Dr. Jur ten Berg, MD, PhD - ACC 2020

Challenges in prescribing DOACs for stroke prevention in AF

5' education - Mar. 2, 2020 - Prof. Freek Verheugt and John Eikelboom

Smartphone-based AF screening in the general population

5' education - Oct. 28, 2019 - Paris, France - Tine Proesmans

Clear results with NOAC monotherapy in patients with CAD and AF

3' education - Sep. 2, 2019 - Prof. Freek Verheugt

Better outcomes in patients with AF and ACS/PCI with NOAC vs. VKA and when dropping aspirin

3' education - Mar. 17, 2019 - New Orleans, LA, USA - John Alexander, MD

Proof-of-concept study shows 84% true AF in those with irregular pulse detected with smartwatch

3' education - Mar. 16, 2019 - New Orleans, LA, USA - Michael Valentine, MD

Population screening for atrial fibrillation with a smartphone

10' education - Aug. 26, 2018 - Munich, Germany - Prof. dr. Pieter Vandervoort - Genk, Belgium

Atrial fibrillation & HFpEF: Novel device and therapeutic approaches

10' education - May 27, 2018 - ESC Heart Failure 2018, Vienna - Dipak Kotecha - Birmingham, UK - Online CME

Considerations on antithrombotic treatment of VTE and AF patients

10' education - Mar. 8, 2018 - Prof. Menno Huisman and dr. Alexander Cohen

Neurotoxin injection did not prevent the common complication of AF after cardiac surgery

3' education - Nov. 15, 2017 - AHA 2017 - Anaheim, CA, USA - Nathan Waldron, MD - Durham, NC, USA.

Initiating digoxin in AF patients associated with early hazard of sudden death

3' education - Mar. 19, 2017 - ACC 2017, Washington, DC, USA - Dr. Renato Lopes

Tailoring oral anticoagulation in elderly patients with AF

3' education - Nov. 12, 2016 - New Orleans, LA, USA - Christopher B. Granger, MD (Durham, NC, USA)

Outstanding questions and ongoing studies on the use of NOACs

3' education - Oct. 7, 2016 - Berg en Dal, The Netherlands - Prof. Chris Granger, MD (Durham, NC, USA)

Oral anticoagulation in daily clinical practice in varous patient populations

10' education - Oct. 6, 2016 - The Netherlands - Prof. Chris Granger, MD (Durham, NC, USA) and Marc Brouwer, MD (Nijmegen, The Netherlands)

Inadequate anticoagulant treatment for stroke prevention in atrial fibrillation

3' education - Apr. 1, 2016 - VBWG Meeting at ACC 2016, Chicago, IL, USA - Christian T. Ruff, MD - Boston, MA, USA
##SCROLLER_ITEMS_FULL_TITLE##

Where are we with HF patients with AF?

3' education - Oct. 31, 2015 - HF Summit, Barcelona, Spain - Dr. Dipak Kotecha
##SCROLLER_ITEMS_FULL_TITLE##

Translating new clinical trial data of DOACs for stroke prevention into clinical practice

3' education - Mar. 30, 2014 - VBWG at ACC - Michael Ezekowitz MD, PhD

Modified CHADS2 shows best predictive performance for stroke across spectrum of kidney function

Literature - Apr. 13, 2021 - De Jong Y et al. - Eur Heart J. 2021

This study validated six risk scores for ischemic stroke in patients with AF across the spectrum of kidney function. The Modified CHADS2 score showed most consistent predictive performance in all kidney function categories.

Causal relationship between blood pressure and AF risk

Literature - Mar. 2, 2021 - Georgiopoulos G, et al. - Eur J Prev Cardiol. 2021

This Mendelian randomization study provided first evidence that the relationship between BP and risk for new-onset AF is likely causal.

Enhanced safety advantage with DOAC in women with AF

Literature - Mar. 1, 2021 - Zelniker TA et al. - Circulation. 2021

Effect of edoxaban versus warfarin on the primary efficacy endpoint and primary safety endpoint was similar in women and men. However, edoxaban reduced risk of several bleeding outcomes to a greater extend in women compared to men.

First-line therapy of cryoballoon ablation reduces AF recurrence

Literature - Feb. 9, 2021 - Andrade JG, et al. - N Engl J Med. 2021

In a randomized trial of patient with paroxysmal AF, initial strategy of cryoballoon ablation significantly reduced rate of recurrence of atrial tachyarrhythmia compared to antiarrhythmic drug therapy.

Alcohol consumption increases risk of incident AF

Literature - Jan. 28, 2021 - Csengeri D et al., - Eur Heart J. 2021

This study in a large community-based cohort showed that even low amounts of alcohol consumption are associated with increased risk of incident AF.

An overview of the global burden of CVD and risk factors from 1990 to 2019

Literature - Jan. 14, 2021 - Roth GA, et al. - J Am Coll Cardiol. 2020

Global CVD burden has increased in almost all regions outside high-income countries. The increase was largely due to population growth and aging. In addition, attribution of risk factors like SBP, BMI, and dietary risk increased worldwide.

NOAC non-inferior to warfarin in AF patients with bioprosthetic mitral valve

News - Nov. 15, 2020

AHA 2020 Use of rivaroxaban was as effective as warfarin in reducing the net clinical outcome of all-cause mortality, major CV events or major bleeding in AF patients with a bioprosthetic mitral valve.

Omega-3 fatty acids and/or vitamin D3 supplementation do not reduce incident AF

News - Nov. 14, 2020

AHA 2020 The VITAL-Rhythm trial showed that daily omega-3 fatty acids and/or vitamin D3 supplementation had no effect on the primary prevention of incident AF.

Nonrecommended dosing of NOACs associated with higher risk of all-cause mortality in AF

Literature - Oct. 6, 2020 - Camm AJ et al. - J Am Coll Cardiol 2020

In the GARFIELD-AF registry, most AF patients received recommended doses of NOAC. Those with nonrecommended doses (underdosing or overdosing) had increased risk of mortality compared to those with recommended doses.

Updates in the 2020 AF guidelines

3' education - Sep. 2, 2020 - Prof. Isabelle van Gelder, MD
During the ESC Congress, the 2020 AF guidelines have been presented. Prof. Van Gelder gives an overview of the most important changes.

ESC 2020 During the ESC Congress, the 2020 AF guidelines have been presented. Prof. Van Gelder gives an overview of the most important changes.

Benefit with early rhythm control in patients with recently diagnosed AF

News - Aug. 29, 2020
**ESC 2020** The EAST-AFNET4 trial showed that patients with early AF and CV conditions benefit from early rhythm control therapy compared to patients who received standard therapy.

ESC 2020 The EAST-AFNET4 trial showed that patients with early AF and CV conditions benefit from early rhythm control therapy compared to patients who received standard therapy.

Early rhythm control in AF patients improves outcomes

3' education - Aug. 29, 2020 - Prof. Paulus Kirchhof, MD
Prof. Kirchhof shares the findings of the EAST-AF NET 4 trial, which evaluated the effect of early rhythm control in patients who were recently diagnosed with AF compared to usual care.

ESC 2020 Prof. Kirchhof shares the findings of the EAST-AF NET 4 trial, which evaluated the effect of early rhythm control in patients who were recently diagnosed with AF compared to usual care.